Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration

被引:8
作者
Aggio, Fabio Bom [1 ]
Farah, Michel Eid [1 ]
Melo, Gustavo Barreto [1 ]
机构
[1] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2006年 / 84卷 / 05期
关键词
D O I
10.1111/j.1600-0420.2006.00759.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:713 / 714
页数:3
相关论文
共 3 条
[1]   Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration [J].
Avery, RL ;
Pieramici, DJ ;
Rabena, MD ;
Castellarin, AA ;
Nasir, MA ;
Giust, MJ .
OPHTHALMOLOGY, 2006, 113 (03) :363-372
[2]   Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration [J].
Axer-Siegel, R ;
Ehrlich, R ;
Rosenblatt, I ;
Kramer, M ;
Priel, E ;
Yassur, Y ;
Weinberger, D .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (04) :453-459
[3]   Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration [J].
Rosenfeld, PJ ;
Moshfeghi, AA ;
Puliafito, CA .
OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04) :331-335